在帕金森病中便微生物群移植:试点研究以确定安全性和耐受性
Michele De Sciscio1, Robert V Bryant2,3,4, Sarah Haylock-Jacobs3,5
1Neurology Unit, Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, Australia. michele.desciscio@sa.gov.au.
NPJ Parkinson's disease
|July 9, 2025
概括
便微生物群移植 (FMT) 对于帕金森病 (PD) 患者来说是安全的,可提供暂时的症状缓解. 延长的FMT治疗显示出减少运动关闭时间的潜力,但在六个月内缺乏持续的益处.
科学领域:
- 神经科学是一个神经科学.
- 胃肠病学 胃肠病学
- 微生物学 微生物学
背景情况:
- 肠道微生物群的改变越来越多地与帕金森病 (PD) 的进展和治疗反应有关.
- 便微生物群移植 (FMT) 是一个有前途的治疗途径,用于调节PD的肠道微生物群.
研究的目的:
- 评估在患有轻度至中度帕金森病的患者中FMT的安全性和耐受性.
- 在六个月的时间内评估FMT对PD运动和非运动症状的影响.
主要方法:
- 一项开放式试点研究涉及12名患有轻度至中度PD的患者.
- FMT是通过阴囊给药,持续时间为6个月.
- 评估安全性,耐受性,运动症状,非运动症状和生活质量.
主要成果:
- 发现FMT是安全的,耐受性很好,只有轻微的,短暂的胃肠道副作用.
- 在两个月的标志上观察到每天"关闭"时间 (运动症状波动) 减少的趋势.
- 两个月后,人们注意到生活质量和非运动性得分的暂时改善,但在六个月后没有持续下去.
结论:
- 在帕金森病中,延长的FMT治疗是安全的和可以容忍的.
- 虽然FMT显示了减少运动"关闭"时间和改善非运动症状的潜力,但这些效应在整个六个月的治疗时间内都没有持续.
相关概念视频
Parkinson's Disease: Treatment
389
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
389
Parkinson's Disease: Overview
716
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
716
Drugs for Treatment of Diarrhea-Predominant IBS
308
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
308
What is Monogastric Digestion?
72.6K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
72.6K


